Integrated Filing — IndAS



General information about company
Scrip Code 500650
NSE Symbol EXCELINDUS
MSEI Symbol NOTLISTED
ISIN INE369A01029
Name of company Excel Industries Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 30-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-May-2025   14:00:00
End date and time of board meeting 14-May-2025   18:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 2478422000 9780677000
Other income 57419000 302212000
Total income 2535841000 10082889000
2 Expenses
(a) Cost of materials consumed 1385270000 5186258000
(b) Purchases of stock-in-trade 16569000 72567000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -42819000 -196511000
(d) Employee benefit expense 327861000 1218020000
(e) Finance costs 2596000 23686000
(f) Depreciation, depletion and amortisation expense 87583000 340662000
(f) Other Expenses
1 other Expenses 595880000 2304681000
Total other expenses 595880000 2304681000
Total expenses 2372940000 8949363000
3 Total profit before exceptional items and tax 162901000 1133526000
4 Exceptional items 0 0
5 Total profit before tax 162901000 1133526000
6 Tax expense
7 Current tax 36054000 267145000
8 Deferred tax 2781000 9135000
9 Total tax expenses 38835000 276280000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 124066000 857246000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 -4112000
16 Total profit (loss) for period 124066000 853134000
17 Other comprehensive income net of taxes -560412000 832594000
18 Total Comprehensive Income for the period -436346000 1685728000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0 0
Total profit or loss, attributable to non-controlling interests 0 0
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent -436346000 1685728000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0 0
21 Details of equity share capital
Paid-up equity share capital 62853000 62853000
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve 15824317000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 9.87 67.87
Diluted earnings (loss) per share from continuing operations 9.87 67.87
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 9.87 67.87
Diluted earnings (loss) per share from continuing and discontinued operations 9.87 67.87
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 4232999000
Capital work-in-progress 84470000
Investment property 155430000
Goodwill 188528000
Other intangible assets 8768000
Intangible assets under development 43027000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 8752940000
Trade receivables, non-current 0
Loans, non-current 771000
Other non-current financial assets 85875000
Total non-current financial assets 8839586000
Deferred tax assets (net) 2266000
Other non-current assets 107747000
Total non-current assets 13662821000
2 Current assets
Inventories 940468000
Current financial asset
Current investments 2095597000
Trade receivables, current 2159499000
Cash and cash equivalents 122450000
Bank balance other than cash and cash equivalents 40133000
Loans, current 12276000
Other current financial assets 71435000
Total current financial assets 4501390000
Current tax assets (net) 0
Other current assets 99356000
Total current assets 5541214000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 19204035000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 62853000
Other equity 15824317000
Total equity attributable to owners of parent 15887170000
Non controlling interest
Total equity 15887170000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 21761000
Total non-current financial liabilities 21761000
Provisions, non-current 141345000
Deferred tax liabilities (net) 1416486000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 1579592000
Current liabilities
Current financial liabilities
Borrowings, current 512000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 68150000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1301298000
Total Trade payable 1369448000
Other current financial liabilities 146806000
Total current financial liabilities 1516766000
Other current liabilities 97603000
Provisions, current 122904000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 1737273000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 3316865000
Total equity and liabilites 19204035000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Chemicals 2448136000 9687623000
2 Environment and Biotech 30286000 93054000
Total Segment Revenue 2478422000 9780677000
Less: Inter segment revenue 0 0
Revenue from operations 2478422000 9780677000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Chemicals 270180000 1533773000
2 Environment and Biotech -12872000 -56481000
Total Profit before tax 257308000 1477292000
i. Finance cost 2596000 2596000
ii. Other Unallocable Expenditure net off Unallocable income 91811000 91811000
Profit before tax 162901000 1129414000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Chemicals 7641375000 7641375000
2 Environment and Biotech 154805000 154805000
Total Segment Asset 7796180000 7796180000
Un-allocable Assets 11407855000 11407855000
Net Segment Asset 19204035000 19204035000
4 Segment Liabilities
Segment Liabilities
1 Chemicals 1478071000 1478071000
2 Environment and Biotech 66318000 66318000
Total Segment Liabilities 1544389000 1544389000
Un-allocable Liabilities 1772476000 1772476000
Net Segment Liabilities 3316865000 3316865000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 remeasurement gains on net defined benefit plans -30627000 -29139000
2 changes in fair value of equity instruments -627254000 758537000
Total Amount of items that will not be reclassified to profit and loss -657881000 729398000
2 Income tax relating to items that will not be reclassified to profit or loss -97469000 -103196000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -560412000 832594000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1133526000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 23686000
Adjustments for decrease (increase) in inventories 123445000
Adjustments for decrease (increase) in trade receivables, current -317726000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 14059000
Adjustments for decrease (increase) in other non-current assets -3875000
Adjustments for other financial assets, non-current -68198000
Adjustments for other financial assets, current 40937000
Adjustments for other bank balances 5749000
Adjustments for increase (decrease) in trade payables, current -476644000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 52532000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 340661000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 59361000
Adjustments for provisions, non-current -20551000
Adjustments for other financial liabilities, current 7445000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -2945000
Adjustments for dividend income 93046000
Adjustments for interest income 139129000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 40665000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -85537000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -499111000
Net cash flows from (used in) operations 634415000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 16225000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 618190000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 14723000
Cash flows used in obtaining control of subsidiaries or other businesses 4112000
Other cash receipts from sales of equity or debt instruments of other entities 5843642000
Other cash payments to acquire equity or debt instruments of other entities 6002408000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 4743000
Purchase of property, plant and equipment 388451000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 47037000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 93046000
Interest received 92131000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -19173000
Net cash flows from (used in) investing activities -412896000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 512000
Repayments of borrowings 0
Payments of lease liabilities 68384000
Dividends paid 69139000
Interest paid 23686000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -160697000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 44597000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 44597000
Cash and cash equivalents cash flow statement at beginning of period 77853000
Cash and cash equivalents cash flow statement at end of period 122450000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s Price Waterhouse Chartered Accountants LLP Yes 30-Nov-2026